GW&K Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
GW&K Investment Management's NEO Position: Q2 2026 in Review
GW&K Investment Management reduced its NeoGenomics (NEO) stake by 2.8% in Q2 2026, selling an estimated $592K and leaving 2,129,421 shares worth $31.1M. The position accounts for 0.24% of the portfolio, ranked #155.
GW&K Investment Management first reported a position in NEO in Q3 2022 and has held it in 16 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- GW&K Investment Management held 2,129,421 shares of NeoGenomics worth $31.1M as of Q2 2026.
- GW&K Investment Management sold 61,337 NeoGenomics shares in Q2 2026, an estimated $592K.
- NeoGenomics made up 0.24% of GW&K Investment Management's portfolio in Q2 2026, its #155 holding.
- GW&K Investment Management first reported a position in NeoGenomics in Q3 2022 and has held it in 16 quarters since.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.